{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:26:42Z","timestamp":1793622402280,"version":"4.5.0"},"reference-count":86,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2026,11,2]]},"DOI":"10.1080\/14737175.2026.2733192","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:30:33Z","timestamp":1789623033000},"page":"1041-1051","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Profiling zuranolone as a treatment option for postpartum depression"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3003-2033","authenticated-orcid":false,"given":"Christina","family":"Gonzalez-Torres","sequence":"first","affiliation":[{"name":"Western University of Ontario","place":["London, Canada"]},{"name":"Parkwood Finch Family Health Building","place":["London, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-8245","authenticated-orcid":false,"given":"Verinder","family":"Sharma","sequence":"additional","affiliation":[{"name":"Western University of Ontario","place":["London, Canada"]},{"name":"Parkwood Finch Family Health Building","place":["London, Canada"]},{"name":"London Health Sciences Centre","place":["London, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291725000601"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041217-011106"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1745506519844044"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.87"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2008.00606.x"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2019.1699575"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/0167482X.2015.1089228"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2018.12.001"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2576"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz333"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2016.05.010"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0242-2"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105424"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200101000-00016"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000358838"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3572-8"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70288"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2013.11.056"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.11.014"},{"issue":"3","key":"e_1_3_6_23_1","first-page":"181","article-title":"Antepartum and postpartum depression: healthy mom, healthy baby","volume":"59","author":"Moses-Kolko EL","year":"2004","unstructured":"Moses-Kolko EL, Roth EK. Antepartum and postpartum depression: healthy mom, healthy baby. J Am Med Womens Assoc (1972). 2004;59(3):181\u2013191.","journal-title":"J Am Med Womens Assoc (1972)"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2004.02.006"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-101414-020426"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005200"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.813130"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2020.102779"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.07.126"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2021.103162"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20865"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0007"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/19371918.2019.1635947"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.62.6.pss6206_0619"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01202-x"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06977-z"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.11.1217"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph3010019"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005202"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/07067437241303031"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2010.00809.x"},{"key":"e_1_3_6_42_1","unstructured":"Biogen receives Health Canada authorization for ZURZUVAETM (zuranolone) the first and only treatment indicated for adults with postpartum depression in Canada [Internet]. Biogen. 2025 [cited 2025 May 15]. Available from: https:\/\/www.biogen.ca\/en-ca\/news\/2025-12-09-news.html"},{"key":"e_1_3_6_43_1","unstructured":"Biogen receives European commission approval for ZURZUVAE\u00ae (zuranolone) the first and only treatment approved for women with postpartum depression in Europe [Internet]. Biogen. 2025 [cited 2026 Jul 21]. Available from: https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-receives-european-commission-approval-zurzuvaer"},{"key":"e_1_3_6_44_1","unstructured":"MHRA approves zuranolone to treat postnatal depression in adults following childbirth [Internet]. gov.uk. UK: Medicines and Healthcare products Regulatory Agency; 2025. Available from: https:\/\/www.gov.uk\/government\/news\/mhra-approves-zuranolone-to-treat-postnatal-depression-in-adults-following-childbirth"},{"key":"e_1_3_6_45_1","unstructured":"FDA approves ZURZUVAETM (zuranolone) the first and only oral treatment approved for women with postpartum depression and issues a complete response letter for major depressive disorder [Internet]. Biogen. 2023 [cited 2025 May 15]. Available from: https:\/\/investors.biogen.com\/news-releases\/news-release-details\/fda-approves-zurzuvaetm-zuranolone-first-and-only-oral-treatment"},{"key":"e_1_3_6_46_1","unstructured":"US Food and Drug Administration. Zurzuvae Medication Guide [Internet]. US Food and Drug Administration; 2024 [cited 2026 Jul 21]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/217369s001lbl.pdf#page=22"},{"key":"e_1_3_6_47_1","unstructured":"Zurzuvae product information [Internet]. European Medicines Agency; 2025 [cited 2026 Jul 21]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zurzuvae-epar-product-information_en.pdf"},{"key":"e_1_3_6_48_1","unstructured":"Zurzuvae 20 mg hard capsules [Internet]. Electronic medicines compendium. 2026. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/101316\/smpc"},{"key":"e_1_3_6_49_1","unstructured":"Shionogi receives approval in Japan to manufacture and market ZURZUVAE\u00ae capsules 30 mg for the treatment of major depressive disorder [Internet]. Shionogi & Co.; 2025. Available from: https:\/\/www.shionogi.com\/global\/en\/news\/2025\/12\/E_20251222.html"},{"key":"e_1_3_6_50_1","unstructured":"Nalubola PR. Sage therapeutics Inc.; withdrawal of approval of a new drug application for ZULRESSO (brexanolone) solution 100 milligrams\/20 milliliters. Federal Register [Internet]. 2025 Mar 3; Available from: https:\/\/www.federalregister.gov\/documents\/2025\/03\/14\/2025-04101\/sage-therapeutics-inc-withdrawal-of-approval-of-a-new-drug-application-for-zulresso-brexanolone"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.07.017"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-019-00986-0"},{"key":"e_1_3_6_53_1","unstructured":"Sage therapeutics and biogen. ZURZUVAE (zuranolone) capsules for oral use civ: US prescribing information [Internet]. 2023 [cited 2026 Mar 31]. Available from: https:\/\/dailymed.nlm.nih.giv\/dailymed\/drugInfo.cfm?setid=f18e53b0-d0bb-422d-8de7-ab64b7292b29"},{"key":"e_1_3_6_54_1","unstructured":"Biogen MA Inc Sage Therapeutics. Zurzuvae - zuranolone capsule [Internet]. DailyMed. National Library of Medicine; 2024 [cited 2026 Apr 20]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f18e53b0-d0bb-422d-8de7-ab64b7292b29"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.1559"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220785"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25cr15876"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2025.02.004"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220459"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14445"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13917"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2806"},{"key":"e_1_3_6_63_1","unstructured":"Gunduz-Bruce H Jonas J Sankoh A et al. Open-label phase 2 trial of the oral neuroactive steroid GABAA receptor positive allosteric modulator zuranolone in bipolar disorder I and ii. 2020."},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117277"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29731"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2013.4438"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-015-0577-1"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14475"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2334160"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31551-4"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14537"},{"key":"e_1_3_6_72_1","unstructured":"Dunbar J Lasser R Rana N. Abuse potential of zuranolone in nondependent recreational users of central nervous system depressants: a randomized double-blind active- and placebo controlled crossover study. 2022."},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241282777"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001873"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.377"},{"key":"e_1_3_6_76_1","unstructured":"Zuranolone [Internet]. Drugs and lactation database (LactMed\u00ae) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006 [cited 2026 Mar 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594292\/"},{"key":"e_1_3_6_77_1","unstructured":"MHRA approves zuranolone to treat postnatal depression in adults following childbirth [Internet]. Gov.Uk. Medicines and Healthcare Products Regulatory Agency. 2025 [cited 2025 May 15]. Available from: http:\/\/www.gov.uk\/government\/news\/mhra-approves-zuranolone-to-treat-postnatal-depression-in-adults-following-childbirth"},{"key":"e_1_3_6_78_1","unstructured":"Biogen receives European commission approval for ZURZUVAE\u00ae (zuranolone) the first and only treatment approved for women with postpartum depression in Europe [Internet]. Biogen. 2025 [cited 2025 May 15]. Available from: http:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-receives-european-commission-approval-zurzuvaer"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-024-01074-9"},{"key":"e_1_3_6_80_1","unstructured":"Biogen Canada Inc. Product monograph - zurzuvae [Internet]. Toronto (ON) Canada: Biogen Canada Inc.; 2025 [cited 2026 Apr 20]. Available from: https:\/\/www.biogen.ca\/content\/dam\/corporate\/americas\/canada\/en-ca\/medicines\/zurzuvae\/ZURZUVAE_PM_EN.pdf"},{"key":"e_1_3_6_81_1","unstructured":"Zurzuvae (zuranolone) capsules [Internet]. Biogen Supernus pharmaceuticals. 2026 [cited 2026 Jul 22]. Available from: https:\/\/www.zurzuvae.com\/"},{"key":"e_1_3_6_82_1","unstructured":"Zurzuvae prices coupons copay cards & patient assistance [Internet]. Drugs.com. [cited 2025 May 1]. Available from: https:\/\/www.drugs.com\/price-guide\/zurzuvae"},{"key":"e_1_3_6_83_1","unstructured":"Antenatal and postnatal mental health: clinical management and service guidance. Internet. National Institute for Health and Care Excellence; 2020. Available from: https:\/\/www.nice.org.uk\/guidance\/cg192\/resources\/antenatal-and-postnatal-mental-health-clinical-management-and-service-guidance-pdf-35109869806789"},{"issue":"8","key":"e_1_3_6_84_1","first-page":"CD014624","article-title":"Brexanolone, zuranolone and related neurosteroid GABAA receptor positive allosteric modulators for postnatal depression","volume":"2025","author":"Wilson CA","year":"2025","unstructured":"Wilson CA, Wilson CA, Robertson L, et al. Brexanolone, zuranolone and related neurosteroid GABAA receptor positive allosteric modulators for postnatal depression. Cochrane Database Syst Rev. 2025;2025(8):CD014624.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.61622\/rbgo\/2024rbgo79"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/87551225241287383"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S466260"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.268"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2026.2733192","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737175.2026.2733192","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2026.2733192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:39:49Z","timestamp":1793619589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2026.2733192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,2]]}},"alternative-id":["10.1080\/14737175.2026.2733192"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2026.2733192","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}